Related Experiment Video
Updated: Jun 26, 2026
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Protein tyrosine phosphatases regulate asthma development in a murine asthma model
Philippe Pouliot1, Pierre Camateros, Danuta Radzioch
1Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
Journal of Immunology (Baltimore, Md. : 1950)
|January 22, 2009
Summary
Protein tyrosine phosphatases (PTPs) are crucial for allergic asthma development. Inhibiting PTPs during sensitization or challenge in mice significantly reduced asthma symptoms, suggesting PTPs as potential therapeutic targets.
Area of Science:
- Immunology
- Molecular Biology
- Respiratory Medicine
Background:
- Allergic asthma is a chronic Th2-inflammatory disease.
- Intracellular signaling pathways in asthma are under investigation.
- Protein tyrosine kinases (PTKs) are studied, but protein tyrosine phosphatases (PTPs) are less explored.
Purpose of the Study:
- To investigate the role of PTPs in allergic asthma development.
- To determine if PTP inhibition can ameliorate asthma features.
- To explore PTPs as potential therapeutic targets for asthma.
Main Methods:
- Utilized a murine model of allergic asthma.
- Administered the PTP inhibitor bis-peroxovanadium bpV(phen) during allergen sensitization or challenge.
- Assessed key asthma indicators: serum IgE, lung inflammation, eosinophilia, airway hyperresponsiveness, and cytokine profiles.
Main Results:
- PTP inhibition during allergen sensitization significantly reduced IgE, lung inflammation, eosinophilia, and airway hyperresponsiveness.
- PTP inhibition during allergen challenge yielded similar improvements in asthma features.
- bpV(phen) treatment modulated spleen cytokine expression, promoting Th1 and suppressing Th2 responses.
Conclusions:
- Intact PTP activity is essential for the full induction of allergic asthma in this model.
- PTPs play a pivotal regulatory role in asthma pathogenesis.
- Targeting PTPs offers a promising new therapeutic strategy for allergic asthma.
More Related Videos
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...